Conservative management of early-stage epithelial ovarian cancer: Results of a large retrospective series

Annals of Oncology

Volumn 24, Issue 1, 2013, Pages 138-144

  Fruscio, R ^a,b   Corso, S ^a,b   Ceppi, L ^a,b   Garavaglia, D ^b   Garbi, A ^a,b   Floriani, I ^b   Franchi, D ^a,b   Cantu M G ^a,b   Bonazz, C M ^a,b   Milani, R ^a,b   Mangioni, C ^a,b   Colombo, N ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Fertility sparing surgery; Obstetrical outcome; Ovarian cancer; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADOLESCENT; ADULT; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CYSTECTOMY; EARLY CANCER; FEMALE; FERTILITY SPARING SURGERY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVARIECTOMY; OVARY CARCINOMA; OVERALL SURVIVAL; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; TREATMENT RESPONSE;

EID: 84871551225     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds241     Document Type: Article

References (23)

1. FIGO (International Federation of Gynecology and Obstetrics). Annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2003; 83(Suppl. 1): 1-229.
2. Colombo N, Peiretti M, Parma G et al. ESMO Guidelines Working Group. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): v23-v30.
3. Morice P, Denschlag D, Rodolakis A et al. Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors. Int J Gynecol Cancer 2011; 21(5): 951-963.
4. Zanetta G, Chiari S, Rota S et al. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol 1997; 104(9): 1030-1035.
5. Schilder JM, Thompson AM, DePriest PD et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertilitysparing therapy. Gynecol Oncol 2002; 87(1): 1-7.
6. Morice P, Leblanc E, Rey A et al. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique). Hum Reprod 2005; 20(5): 1379-1385.
7. Borgfeldt C, Iosif C, Måsbäck A. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2007; 134(1): 110-114.
8. Park JY, Kim DY, Suh DS et al. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol 2008; 110(3): 345-353.
9. Anchezar JP, Sardi J, Soderini A. Long-term follow-up results of fertility sparing surgery in patients with epithelial ovarian cancer. J Surg Oncol 2009; 100(1): 55-58.
10. Schlaerth AC, Chi DS, Poynor EA et al. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Int J Gynecol Cancer 2009; 19(7): 1199-1204.
11. Kwon YS, Hahn HS, Kim TJ et al. Fertility preservation in patients with early epithelial ovarian cancer. J Gynecol Oncol 2009; 20(1): 44-47.
12. Satoh T, Hatae M, Watanabe Y et al Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol 2010; 28(10): 1727-1732.
13. Kajiyama H, Shibata K, Suzuki S et al. Fertility-sparing surgery in young women with invasive epithelial ovarian cancer. Eur J Surg Oncol 2010; 36(4): 404-408.
14. International Federation of Gynecology and Obstetrics. Changing in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987; 156: 263-264.
15. Colombo N, Guthrie D, Chiari S et al. International Collaborative Ovarian Neoplasm Trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 2003; 95(2): 125-132.
16. Trimbos JB, Vergote I, Bolis G et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003; 95: 113-125.
17. Trimbos JB, Parmar M, Vergote I et al. International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003; 95(2): 105-112.
18. Trimbos B, Timmers P, Pecorelli S et al. Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial. J Natl Cancer Inst 2010; 102(13): 982-987.
19. Wright JD, Shah M, Mathew L et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer 2009; 115(18): 4118-4126.
20. Kajiyama H, Shibata K, Mizuno M et al. Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery. Br J Cancer 2011; 105(9): 1288-1294.
21. Kurman RJ, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010; 34(3): 433-443.
22. Marchini S, Mariani P, Chiorino G et al. Analysis of gene expression in early-stage ovarian cancer. Clin Cancer Res 2008; 14(23): 7850-7860.
23. Marchini S, Cavalieri D, Fruscio R et al. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. Lancet Oncol 2011; 12(3): 273-285.